Cardiac mast cell-mediated activation of gelatinase and alteration of ventricular diastolic function

Amanda L Chancey1, Gregory L Brower, Joseph S Janicki

  • 1Department of Anatomy, Physiology, and Pharmacology, Auburn University, Auburn, Alabama 36849, USA.

Insights

Cardiac mast cells, though sparse, can activate matrix metalloproteinases (MMPs). Degranulation induced myocardial edema, MMP-2 activation, and extracellular matrix degradation, potentially leading to ventricular dilatation.

Area of Science:

  • Cardiovascular Biology
  • Cellular Biology
  • Biochemistry

Background:

  • Mast cells reside in the myocardium and contain proteases that can activate matrix metalloproteinases (MMPs).
  • The functional significance of cardiac mast cells in activating MMPs within the normal heart remains unclear due to their relatively low density.

Purpose of the Study:

  • To investigate the effect of chemically induced cardiac mast cell degranulation on MMP activation and extracellular matrix in an isolated rat heart model.
  • To determine if the quantity of mast cells in a normal heart is sufficient to mediate MMP activation and extracellular matrix degradation.

Main Methods:

  • Isolated, blood-perfused, functioning rat hearts were utilized.
  • Cardiac mast cell degranulation was chemically induced using compound 48/80.
  • Histamine levels, myocardial water content, MMP-2 activation, and collagen volume fraction were measured.

Main Results:

  • Mast cell degranulation increased coronary efflux histamine levels by 15%.
  • Myocardial water content significantly increased, indicating edema (80.1% vs 77.4%).
  • MMP-2 activation substantially increased (126%), and myocardial collagen volume fraction markedly decreased (0.46% vs 0.97%).
  • Modest ventricular dilatation was observed despite expected stiffness from edema.

Conclusions:

  • The number of mast cells in normal hearts is sufficient to activate MMPs.
  • Cardiac mast cell degranulation leads to extracellular matrix degradation.
  • This degradation has the potential to cause subsequent ventricular dilatation.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...